Bisphosphonates in Bone Disease
From the Laboratory to the Patient
- Publisher's listprice EUR 118.00
-
50 055 Ft (47 672 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 10 011 Ft off)
- Discounted price 40 044 Ft (38 138 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
50 055 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 4
- Publisher Academic Press
- Date of Publication 18 April 2000
- ISBN 9780122603716
- Binding Hardback
- No. of pages212 pages
- Size 228x152 mm
- Weight 550 g
- Language English 0
Categories
Long description:
This book is an essential handbook on bisphosphonates, the most widely used new class of drugs for osteoporosis therapy. It reviews basic physiology in addition to the indications and adverse reactions of these drugs.
Bisphosphonates in Bone Disease, Fourth Edition, discusses the compounds' chemistry, mechanisms of action, and animal toxicology before presenting a clinical picture of the diseases treated by bisphosphonates. The book provides a table listing the trade names of the commercially available bisphosphonates, registered indications, and the available forms for various countries. The revised Fourth Edition contains approximately 50% new material, including information on all of the latest drugs.
MoreTable of Contents:
Bone and Mineral Metabolism:
Bone Physiology:
Morphology.
Composition of bone.
Modeling and remodeling.
Calcium homeostasis.
Bone as an organ.
Assessment of bone turnover.
Bisphosphonates-Preclinical:
Background to the pharmacological development:
Chemistry.
Actions.
Physicochemical effects.
Biological effects.
Inhibition of bone resorption.
Inhibition of mineralization.
Pharmocokinetics:
Intestinal absorption.
Distribution.
Renal clearance.
Other modes of application.
Animal toxicology:
Acute toxicology.
Nonacute toxicology.
Bisphosphonates-clinical:
Introduction.
Paget's Disease:
Definition.
Epidemiology.
Pathophysiology.
Clinical manifestations.
Treatment with drugs other than bisphosphonates.
Treatment with bisphosphonates.
Osteolytic tumor-induced bone disease:
Definition.
Pathophysiology.
Clinical manifestations.
Treatment with drugs other than bisphosphonates.
Treatment with bisphosphonates.
Non-tumor induced hypercalcemia:
Definition.
Pathophysiology.
Clinical manifestations.
Treatment with drugs other than bisphosphonates.
Treatment with bisphosphonates.
Osteoporosis:
Definition.
Epidemiology.
Pathophysiology.
Clinical manifestations.
Treatment with drugs other than bisphosphonates.
Treatment with bisphosphonates.
Heterotopic calcification and ossification:
Definition.
Pathophysiology.
Clinical manifestations.
Treatment with drugs other than bisphosphonates.
Treatment with bisphosphonates.
Other diseases:
Adverse events:
Bisphosphonates in general.
Individual bisphosphonates.
Contraindications.
Future prospects.
Commercially available bisphosphonates:
Index.
